A case of non-mosaic 47,
XXX presenting as placental site trophoblastic, tumor secondary to partial mola
ABSTRACT
Background:
Placental trophoblastic tumor is a very rare form of gestational trophoblastic
disease (GTD). There are some case reports in which some tumors have been
associated with Trisomy X. Objective: is to inform and suggest a possible
management for similar cases in a future. Material and methods: A systematic
search was carried out in the bibliography and subsequent surgery. Case:
Patient with karyotype 47, XXX and ETG. The associated phenotype consisted of a
prominent forehead, epicanthal fold in both eyes, micrognathia with dental
crowding. The biomarkers CKAE1/AE3, Ki75 were positive. The pathology report
suggests an incomplete atypical mole. The final diagnosis was trophoblastic
tumor of the placental site. Conclusion: We recommend hysterectomy with
preservation of the ovaries if they are not involved.
Keywords: gestational trophoblastic disease; hydatidiform
mole; trisomy; trophoblasts; trophoblastic neoplasms; hysterectomy.
Un
caso 47 XXX sin mosaico que se presenta con un tumor trofoblástico del sitio
placentario secundario a mola parcial
RESUMEN
Antecedentes:
El tumor trofoblástico placentario es una forma muy rara de enfermedad
trofoblástica gestacional (ETG). Existen algunos informes de casos en los que
algunos tumores se han asociado a la Trisomía X. Objetivo: es informar y
sugerir un posible manejo para casos similares en un futuro. Material y
métodos: Se realizó una búsqueda sistemática en la bibliografía y posterior cirugía.
Caso: Paciente con cariotipo 47, XXX y ETG. El fenotipo asociado consistía en
frente prominente, pliegue epicántico en ambos ojos, micrognatia con
apiñamiento dental. Los biomarcadores CKAE1/AE3, Ki75 fueron positivos. El
informe patológico sugiere una mola atípica incompleta. El diagnóstico final
fue de tumor trofoblástico de sitio placentario. Conclusiones: Se recomienda la
histerectomía con preservación de los ovarios si no están comprometidos.
Palabras
clave: enfermedad
trofoblástica gestacional; mola hidatiforme; trisomía; trofoblastos; neoplasias
trofoblásticas; histerectomía.
Artículo recibido 01 abril 2023
Aceptado para publicación: 15 abril 2023
INTRODUCTION
Trisomy X (47, XXX) is a sex chromosome
aneuploidy condition first described by Jacobs 1 in 1959. In 30% of
cases an advanced maternal age is associated, along with greater probability of
non-disjunction events in meiosis2.
In girls with trisomy X, two of the three
chromosomes are inactivated, and mosaicism occurs in the tissues, and this
could be one of the possible explanations for the phenotypic different findings
2 such as learning disorders, language, development, motor delay, psychological
problems, and kidney anomalies.3,4
Partial mola (PM) characteristically include
the presence of two types of villi (one large, irregular, and hydropic, and the
other small, fibrous, and immature), cisterns on some of the larger villi,
highly irregular villi with scalloped edges, and usually mild to moderate
trophoblastic hyperplasia. circumferential. There may be development of fetal
structures.
Monochemotherapy with methotrexate is
recommended as management in stage I gestational trophoblastic neoplasia (GTN,
High evidence/Strong recommendation). Hysterectomy may be considered as an
alternative to chemotherapy in selected cases when there is localized disease
in the uterus and no desire to preserve fertility, good initial response to the
decrease in hCG levels, but followed by stabilization or progressive or rapid elevation
of new appearance, or poor response to decreased hCG levels.
Placental-site trophoblastic tumor (PSTT)
arises from intermediate trophoblast (extravillous trophoblast), unlike
choriocarcinoma, which arises from villous trophoblast. 5 The term
“intermediate” trophoblast is commonly used to represent all types of
extravillous trophoblast (Table 1). Scully evaluated the morphological aspects
and malignant potential of the condition in 1981, naming it PSTT 6
but it had already been described since 1976 by Kurman, as syncytial
endometritis, and who called it trophoblastic pseudotumor 7
PSTT shows high invasion and deep infiltration
into the myometrium and can penetrate the uterine wall. PSTT generally lacks
extensive bleeding, although vascular involvement is common. The histologic
morphology is often equivocal, and diagnosis depends on immunohistochemical
staining. The predominance of cytotrophoblastic cells is characteristic, and in
immunohistochemistry many prolactin-producing cells and few gonadotropin-producing
cells are found, for which the production of sub β hCG is variable or absent. It tends to remain confined to the uterus,
with metastases appearing late in its evolution.
The treatment of these tumors is surgical, and
Hysterectomy is the standard treatment for PSTT limited to the uterus. These
tumors are relatively insensitive to chemotherapy and surgery to remove tumors
have proven to be curative if chemoresistant.
Hereby, we report one of such cases.
CASE
Patient with a personal history of learning
delay since childhood and with a family history of Diabetes Mellitus and
Arterial Hypertension. Patient with 23 years old and personal history: menarche
17 years old, irregular menstrual cycles at a rate of 60-90/2-4 with days,
dysmenorrheic bleeding, BASL: 17 years old, NOSP: 2, denies use of family
planning methods, G1, date of last menstrual period: March 26, 2022: Pregnancy
of 6 weeks of gestation. On physical examination there was comprehension
problem, head with prominent forehead, epicanthic fold of the external angle of
both eyes (figure 1), micrognathia with dental overcrowding, decreased oral
opening, interincisors distance class II (3 cm), palatine mesh class III,
Bellhouse Dore grade III, elongated and slender neck of 29 cm in diameter, cylindrical
thorax, globose abdomen in hypogastrium at the expense of uterus 8 cm below the
umbilical scar, integral limbs, and arachnodactyly.
Genitals corroborated as Tanner 3. Examination
found a short vagina of approximately 3 cm, central cervix, lateralized to the
left, of approximately 1 centimeter, closed, formed, finding uterus of
approximately 14 centimeters by indirect hysterometry.
Among the complementary studies, there is
evidence of elevation of HCG hormone (figure 2) and computed axial tomography
of the abdomen with findings of well-defined 6 mm parapyelic cyst in right
kidney Bosniak I and report of karyotype with 47 XXX interpreted as Trisomy X
(figure 3).
Pathology: biopsy confirmed as a partial mole,
surgical pathology reported arcuate uterus as well as a trophoblastic tumor of
the placental site, confirmed by immunohistochemistry, probably the first
reported case showing these findings. There was also found, within the PM,
syncytotrophoblast hyperplasia with chorionic villus edema, an effect described
in moles many years ago but never reported as a histological phenomenon typical
of moles among patients affected by mono-trisomies, what we just named
Tienda-Estrada phenomenon 8 (figure 4)
MATERIAL AND METHODS
A systematic search was carried out in the
bibliography. Given the rarity of these pathologies presented together, the
recommendations for management, treatment and follow-up are null and there is
no history of it, for which the objective of this article is to inform and
suggest a possible management for similar cases in a future, trying to answer
the question: Which would be most appropriate treatment, including
morbimortality of the patients with these pathologies together.
Ethical aspects
An inter-institutional emergency meeting on
ethical issues was held with the medical oncology, surgical oncology, and
gynecology services, given the patient's age, the importance of the pathologies
and looking after the patient’s lack of desire to have children. The probable
treatments and prognostics were informed to the patient and her couple, taking
the final option of performing hysterectomy and subsequent follow-up with HCG.
DISCUSSION
Trisomy X presents a lot of phenotypic
variability, from practically normality to severe affectations of the
neurological sphere and other systems as we found in our patient4.
Tumors that have been reported in patients with
trisomy X include the following: Ewing sarcoma (1999), Gastric non-Hodgkin
lymphoma (2006), Neuroblastoma (2003), fibrous dysplasia (2019), and
Dysgerminoma of the ovary (1995) (2021), among others 9-10.
PSTT is a rare tumor; the incidence of PSTT is
approximately 1/100,000 of all pregnancies and approximately 1-2% of all GTNs,
while its mortality is 25%. 10 As of 2015, almost 300 cases of PSTT have been
reported worldwide. 11
PSTT might follow any type of pregnancy event,
not infrequently becoming clinically apparent even years later, and there is
great variability in its malignant aggressiveness. 5 Approximately
60% will present after a term pregnancy. The remaining 40% will present after a
mole or an abortion. Baergen et al. found a history of full-term pregnancy in
57% of cases, miscarriage in 17%, and molar pregnancies in 26% of cases. 12
While most NTGs are exquisitely amenable to
chemotherapy, PSTT is relatively chemoresistant. Because hysterectomy is
necessary for proper treatment, it is imperative that PSTTs be diagnosed
correctly.
Histologically, PSTTs are monophasic
proliferations of mostly medium to large mononuclear extravillous trophoblasts,
although multinucleated extravillous trophoblasts may also be present.
Extravillous trophoblast cells show marked nuclear atypia, prominent nucleoli,
eosinophilic to clear cytoplasm, scattered mitoses, and occasional intranuclear
inclusions. Characteristically, tumor cells permeate the myometrium, with
prominent vasocentric proliferation and intravascular spread. High mitotic
activity (>4 mitoses per 10 high-power fields) may indicate a poor
prognosis. 13
The syncytiotrophoblast expresses cytokeratin,
human chorionic gonadotropin (B-hCG), human placental lactogen (hPL) and
placental alkaline phosphatase (PLAP) as well as alpha-inhibin. In contrast,
the intermediate trophoblast of the placental implantation site generally
expresses the same antigens, although to a lesser extent, and instead expresses
epithelial membrane antigen (EMA) and also alpha-inhibin. Tumor cells usually
have a high level of expression of Ki-67 (about 10%-15%).
Immunohistochemical results for the PSTT:
Antigen: CK (+++); hPL (+++); Ki67 (++); P53 (++); P63 (++); Calponin (++); HCG
(+); PLAP (+); Vim (+); SMA (+); S-100 (+); Inhibin (-). (PLAP, placental
alkaline phosphatase; hPL, human placental lactogen; SMA, smooth muscle actin) 14
(figure 5)
It is now accepted that placental-site
trophoblastic tumors differ from other trophoblastic neoplasms in that the
tumor load is not accurately correlated with the concentration of hCG, and that
the tumor might be less sensitive to chemotherapy that is effective in the
other types of trophoblastic neoplasia. 5
The interval from the previous pregnancy to
tumor development is usually less than 2 years, although PSTT has been reported
almost two decades after the previous pregnancy. 15 PSTT is usually
secondary to varieties of pregnancies and often follows full-term labor for a
girl or after an abortion, molar pregnancy, or ectopic pregnancy. 16 PSTT
has also been reported in association with a live twin pregnancy and was
successfully resected during cesarean section. 17 Interestingly, PSTT
can also develop in patients with no history of pregnancy, and PSTT has been
observed in the ovary of a young girl with isosexual precocious puberty 18
and in men. 19
Metastases develop in 30% to 50% of PSTTs at
presentation. 20,21 Recurrence occurs in more than 30% of cases.
The serum β-hCG level in 79% of the patients was below 1000 mIU/mL, 22 and below
400 mIU/mL in 97% of the patients. 23 The level of β-hCG in serum is not proportional to tumor burden 24 nor is it
associated with malignant behavior. 20
Histologic findings cannot distinguish benign
or malignant features of PSTT. However, a high mitotic rate (greater than 10/10
hpf) and substantial hemorrhage and necrosis within the tumor are certainly
indicative of malignancy.
Hysterectomy is recommended for women if it is
not necessary to preserve fertility, as long as the disease is localized to the
uterus. Furthermore, ovarian metastases are rare, and an oophorectomy cannot
prevent postoperative extrauterine metastases or improve prognosis. Therefore,
the ovaries and even fertility can be preserved in young women without ovarian
metastases.
The type of antecedent pregnancy was normal
term pregnancy in 7 (54%), elective or spontaneous abortion in 3 (23%), molar
pregnancy in 2 (15%), and loss of the third trimester in 1 (8%). The median
time from the last pregnancy to diagnosis was 13 months (range 0-240 months).
Serum hCG levels at diagnosis ranged from 1 to 2606 mIU/mL (median 98 mIU/mL). 12
Chen et al. found that among 20 patients with
PSTT the history of pregnancy was term delivery in 88.2% and 1 miscarriage and
1 hydatidiform mole. 26
Similarly, Baergen et al. reported a previous
normal pregnancy rate of 57%, a miscarriage rate of 17%, and a hydatidiform
mole of 26%. 13
RESULTS
We present a case of 47, XXX female presenting
with ultrasonography images showed normal external contour of uterus confirmed
at laparotomy, which was successfully treated even with a dismal prognosis
using simple and follow HCG.
CONCLUSIONS
In Gestational Trophoblastic Disease, patients
with a poor prognosis like this patient, it is suggested to perform a simple
hysterectomy to reach a cure, due to the aggressiveness of the tumor and
resistance to other treatments, as well as rigorous monitoring of the
quantification of the Gonadotropin Hormone Human Chorionic to assess follow-up
on a weekly basis, for which this pilot care protocol is published for similar
cases that may arise.
THANKS
To my father and teacher, Dr. Marcos Tienda
González, for always being present in every academic and life step I have
taken.
To Dr Sánchez for his support and guidance in
this and in all my research.
REFERENCES
Jacobs,
PatriciaA., Baikie, A. G., Court Brown, W. M., Macgregor, T. N., Maclean, N.,
& Harnden, D. G. (1959). EVIDENCE FOR THE EXISTENCE OF THE HUMAN “SUPER
FEMALE.” The Lancet, 274(7100), 423–425.
https://doi.org/10.1016/S0140-6736(59)90415-5
Hassold,
T., Hall, H., & Hunt, P. (2007). The origin of human aneuploidy: where we
have been, where we are going. Human Molecular Genetics, 16(R2), R203–R208.
https://doi.org/10.1093/hmg/ddm243
Tartaglia,
N. R., Howell, S., Sutherland, A., Wilson, R., & Wilson, L. (2010). A
review of trisomy X (47,XXX). Orphanet Journal of Rare Diseases, 5(1), 8.
https://doi.org/10.1186/1750-1172-5-8
Bender, B.
G., Puck, M. H., Salbenblatt, J. A., & Robinson, A. (1990). Cognitive
Development of Children with Sex Chromosome Abnormalities. In
Psychoneuroendocrinology (pp. 138–163). Springer New York.
https://doi.org/10.1007/978-1-4612-3306-0_10
Taylor, K.,
Bean, L. M., Anderson, K. M., Davis, M. A., McHale, M. T., Saenz, C. C., &
Plaxe, S. C. (2016). A population-based study of rare malignant trophoblastic
neoplasms: Epithelioid trophoblastic tumor and placental site trophoblastic
tumor. Gynecologic Oncology, 141, 105–106.
https://doi.org/10.1016/j.ygyno.2016.04.286
Scully, R.
E., & Young, R. H. (1981). Trophoblastic pseudotumor. The American Journal
of Surgical Pathology, 5(1), 75–76.
https://doi.org/10.1097/00000478-198101000-00010
Kurman, R.
J., Scully, R. E., & Norris, H. J. (1976). Trophoblastic pseudotumor of the
uterus.An exaggerated form of “syncytial endometritis” simulating a malignant
tumor. Cancer,
38(3), 1214–1226.
https://doi.org/10.1002/1097-0142(197609)38:3<1214::AID-CNCR2820380323>3.0.CO;2-J
Ezpeleta
JM, López CA. Enfermedad trofoblástica gestacional Aspectos clínicos y
morfológicos. Spain
Journal of pathology. 2002; 35: 187-200. Corpus ID: 31997129. Available in:
http://patologia.es/volumen35/vol35-num2/pdf%20patologia%2035-2/35-2-07.pdf
Lenroot, R.
K., Blumenthal, J. D., Wallace, G. L., Clasen, L. S., Lee, N. R., & Giedd,
J. N. (2014). A case-control study of brain structure and behavioral
characteristics in 47,XXX syndrome. Genes, Brain and Behavior, 13(8), 841–849.
https://doi.org/10.1111/gbb.12180
Wigby, K.,
D’Epagnier, C., Howell, S., Reicks, A., Wilson, R., Cordeiro, L., &
Tartaglia, N. (2016). Expanding the phenotype of Triple X syndrome: A
comparison of prenatal versus postnatal diagnosis. American Journal of Medical
Genetics Part A, 170(11), 2870–2881. https://doi.org/10.1002/ajmg.a.37688
Luiza, J.
W., Taylor, S. E., Gao, F. F., & Edwards, R. P. (2014). Placental site
trophoblastic tumor: Immunohistochemistry algorithm key to diagnosis and review
of literature. Gynecologic Oncology Case Reports, 7, 13–15.
https://doi.org/10.1016/j.gynor.2013.11.001
Alexander,
A. L., Strohl, A. E., Maniar, K. P., & Lurain, J. R. (2020). Placental site
trophoblastic tumor: Successful treatment of 13 cases. Gynecologic Oncology
Reports, 32, 100548. https://doi.org/10.1016/j.gore.2020.100548
Baergen, R.
N., Rutgers, J. L., Young, R. H., Osann, K., & Scully, R. E. (2006).
Placental site trophoblastic tumor: A study of 55 cases and review of the
literature emphasizing factors of prognostic significance. Gynecologic
Oncology, 100(3), 511–520. https://doi.org/10.1016/j.ygyno.2005.08.058
Zeng, X.,
Liu, X., Tian, Q., Xue, Y., & An, R. (2015). Placental site trophoblastic
tumor: A case report and literature review. Intractable & Rare Diseases Research,
4(3), 147–151. https://doi.org/10.5582/irdr.2015.01013
NIGAM, S.,
SINGHAL, N., KUMARGUPTA, S., CHHABRA, D., & MANAKTALA, U. (2004). Placental
site trophoblastic tumor in a postmenopausal female—A case report. Gynecologic
Oncology, 93(2), 550–553. https://doi.org/10.1016/j.ygyno.2004.01.045
Küçük, Z.,
Ergün, Y., Işik, H., Kaya, F., Akgün, Y. A., & Çaydere, M. (2015). A rare
case of uterine rupture due to a placental site trophoblastic tumour in the
rudimentary horn. Journal of Obstetrics and Gynaecology, 35(1), 97–98.
https://doi.org/10.3109/01443615.2014.940301
Liszka, L.,
Wilk, M., Wodolazski, A., Palen, P., & Sikora, J. (2009). Successful
Treatment of Placental Site Trophoblastic Tumor in Twin Pregnancy without
Hysterectomy. Tumori
Journal, 95(1), 108–111. https://doi.org/10.1177/030089160909500120
Arroyo, M.
R., Podda, A., Cao, D., & Rodriguez, M. M. (2009). Placental Site Trophoblastic Tumor in the Ovary
of a Young Child with Isosexual Precocious Puberty. Pediatric and Developmental
Pathology, 12(1), 73–76. https://doi.org/10.2350/08-05-0462.1
Suurmeijer,
A. J. H., Gietema, J. A., & Hoekstra, H. J. (2004). Placental Site
Trophoblastic Tumor in a Late Recurrence of a Nonseminomatous Germ Cell Tumor
of the Testis. American Journal of Surgical Pathology, 28(6), 830–833.
https://doi.org/10.1097/01.pas.0000126053.88174.b5
Feltmate,
C. M., Genest, D. R., Wise, L., Bernstein, M. R., Goldstein, D. P., &
Berkowitz, R. S. (2001). Placental Site Trophoblastic Tumor: A 17-Year
Experience at the New England Trophoblastic Disease Center. Gynecologic
Oncology, 82(3), 415–419. https://doi.org/10.1006/gyno.2001.6265
Chang,
Y.-L., Chang, T.-C., Hsueh, S., Huang, K.-G., Wang, P.-N., Liu, H.-P., &
Soong, Y.-K. (1999). Prognostic Factors and Treatment for Placental Site Trophoblastic
Tumor—Report of 3 Cases and Analysis of 88 Cases. Gynecologic Oncology, 73(2),
216–222. https://doi.org/10.1006/gyno.1999.5344
Papadopoulos,
A. J., Foskett, M., Seckl, M. J., McNeish, I., Paradinas, F. J., Rees, H.,
& Newlands, E. S. (2002). Twenty-five years’ clinical experience with
placental site trophoblastic tumors. The Journal of Reproductive Medicine,
47(6), 460–464.
HASSADIA,
A., GILLESPIE, A., TIDY, J., EVERARDRGN, J., WELLS, M., COLEMAN, R., &
HANCOCK, B. (2005). Placental site trophoblastic tumour: Clinical features and
management. Gynecologic Oncology, 99(3), 603–607.
https://doi.org/10.1016/j.ygyno.2005.06.054
Yalinkaya,
A., Guzel, A. I., Kangal, K., Buyukbayram, H., & Firat, U. (2011). Two
cases of placental site trophoblastic tumor. Taiwanese Journal of Obstetrics
and Gynecology, 50(3), 372–374. https://doi.org/10.1016/j.tjog.2011.01.026
Saso, S.,
Haddad, J., Ellis, P., Lindsay, I., Sebire, N., McIndoe, A., Seckl, M., & Smith,
J. (2012). Placental site trophoblastic tumours and the concept of fertility
preservation. BJOG: An International Journal of Obstetrics & Gynaecology,
119(3), 369–374. https://doi.org/10.1111/j.1471-0528.2011.03230.x
Chen, Y.,
Zhang, X., & Xie, X. (2011). Clinical features of 17 cases of placental
site trophoblastic tumor. International Journal of Gynecology & Obstetrics,
115(2), 204–205. https://doi.org/10.1016/j.ijgo.2011.06.008
ANEXOS
Tables
and figures
Figure Legend:
Patient phenotype showing characteristic facies. Front/Side
Figure Legend: Curve of serum beta
HCG fraction control determination
Figure
Legend: Karyotype of the patient showing an extra copy of X chromosome,
confirming the diagnosis.
Figure
Legend: Microphotographs showing the partial mole and placental site tumor
(H&E, 100 X)
Figure
Legend: Immunohistochemical results
|
Types
|
Histological features
|
A
|
Previllous
trophoblast
|
Mononuclear
trophoblast. It is not part of the villous lining. The pattern is dimorphic,
similar to choriocarcinoma.
|
B
|
Cytotrophoblast
|
Small,
polygonal or ovoid, uniform, mononucleate epithelial cells with clear,
granular cytoplasm. Cell borders appear well defined. Conspicuous nucleoli
and mitoses present.
|
C
|
Syncytiotrophoblast
|
Large
cells that form masses with multiple nuclei and dense, vacuolated acidophilic
cytoplasm. Nuclei dark and sometimes with pyknosis. There is no mitosis. Syncytial pattern.
|
D
|
Villous
intermediate trophoblast
|
|
D1.
Placental implantation site trophoblast
|
Its
appearance varies depending on its location.
In the
endometrium: the cells are polygonal or round with abundant amphophilic
cytoplasm similar to stromal cells with decidual reaction.
In the
myometrium (in decidua or around hypersecretory glands): the cells are
spindle-shaped or ovoid with abundant and eosinophilic or amphophilic cytoplasm.
Vacuoles can be seen and their nuclei exhibit granular chromatin and
irregular contours. They may also be lobed or show pronounced indentations.
The nucleoli are less prominent than those of the cytotrophoblast. They
invade the wall of the spiral arterioles, replacing the muscle fibers but
sparing the supporting structures.
|
|
D2.
Intermediate trophoblast of chorionic type
|
Uniform
cells located lateral to the chorion of the fetal membranes, well cohesive
with eosinophilic or clear (glycogen) cytoplasm. They are smaller than the
trophoblast cells at the placental implantation site but larger than the
cytotrophoblast cells. Occasionally they form islets or cords that insinuate
themselves into the adjacent decidua.
|
|
|
|
|
Table 1.
Types of trophoblast (histological features)